Insulatard Flexpen

Insulin Human, the active ingredient in Insulatard Flexpen, is an insulin presented as a pre‑filled insulin pen for subcutaneous use. It is used to lower blood glucose in patients with diabetes mellitus type 1 and type 2. GNH USA supplies Insulatard Flexpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insulatard Flexpen provides basal insulin therapy for diabetes mellitus, helping to regulate blood glucose levels.

Diabetes mellitus type 1: supplies long‑acting insulin to control fasting glucose and reduce hyperglycemia. Diabetes mellitus type 2: adds basal insulin when oral agents are insufficient to achieve glycaemic targets. Gestational diabetes: may be used under specialist supervision to maintain maternal glucose control.

Insulatard Flexpen may cause a range of adverse reactions. Monitoring and prompt reporting are recommended.

Common Side Effects: - Hypoglycaemia: symptoms of low blood sugar such as shakiness, sweating, or confusion. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: modest increase in body weight with chronic use. - Lipodystrophy: localized changes in fat tissue at injection sites. - Mild allergic reactions: rash or urticaria.

Serious or Rare Side Effects: - Severe hypoglycaemia: loss of consciousness or seizures requiring immediate medical attention. - Anaphylactic reaction: rare systemic allergic response with difficulty breathing or swelling. - Insulin edema: fluid retention causing swelling of extremities. - Hypokalemia: low potassium levels, especially with high insulin doses. - Lipohypertrophy: significant fat accumulation leading to erratic insulin absorption.

When using Insulatard Flexpen, consider the following safety measures.

Dose adjustment: individualize dosing based on regular glucose monitoring and clinical response. Hypoglycaemia risk: educate patients to recognize early signs and have fast‑acting carbohydrates available. Renal impairment: assess kidney function and consider lower doses to avoid prolonged insulin action. Pregnancy: use only if the expected benefit outweighs potential risk to the fetus. Drug interactions: review concomitant medications that may potentiate or diminish insulin effects. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulatard Flexpen can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent sulfonylureas or meglitinides: may cause severe hypoglycaemia. - Beta‑blockers: can mask hypoglycaemia symptoms, delaying recognition. - Excess alcohol: potentiates insulin’s glucose‑lowering effect, increasing hypoglycaemia risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance insulin sensitivity, requiring dose review. - Thiazide diuretics: can raise blood glucose, potentially needing higher insulin doses. - Corticosteroids: increase insulin resistance, possibly necessitating dose escalation.